For a second year, Genetic Signatures Ltd are proudly exhibiting at the 25th International Molecular Medicine TRI-Conference (MMTC) in San Francisco, CA on 12th-14thFebruary 2018. Our US operations team will be exhibiting our growing number of EasyScreenTM viral and infectious disease reagents. Formulated on our proprietary 3base™ technology, the EasyScreenTM reagents fosters more efficient detection of…

  Genetic Signatures are pleased to inform our customers and distributors that we have recently relocated our Sydney Office. Our relocation enables advancement of our growth expectations for the future and further support our customers through our commitment of high quality products and services. Our contact number will remain unchanged. Our new address: 7 Eliza…

Genetic Signatures are exhibiting at the Association for Molecular Pathology (AMP) Annual meeting 2017 in Salt Lake City, Utah 16-18 November. The AMP Annual Meeting is: The premier educational event for molecular pathology professionals from around the world. The only educational event developed and presented by internationally renowned molecular diagnostic professionals.  The dedicated forum for…

Genetic Signatures EasyScreen™ Pathogen Detection Kits will be featured in an oral presentation at the upcoming National Reference Laboratory (NRL) Workshop on Molecular Diagnostics on the 16-17th October 2017 Hobart, Australia. The presentation entitled “A 3baseTM Real-Time Multiplex-PCR for the detection of Extended- Spectrum β -Lactamases (ESBL) and Carbapenemase- Producing Organisms (CPO) will be given…

Genetic Signatures are proud to announce the exhibition and presentation at the 10th European Meeting on Molecular Diagnostics (EMMD) on the 11-13th October 2017 Noordwijk, Netherlands. This biannual event with multiple keynote speakers provides a unique opportunity to showcase applications in novel molecular technologies as well as highlight the key aspects required in Molecular Diagnostics.…

Genetic Signatures are proud to exhibit at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2017 in Hobart, Tasmania on 2-5 July 2017. Genetic Signatures has also been selected to present 4 oral papers at ASM 2017 Tasmania, in the following sessions: Monday 3rd July, 2017 10:30-12:00pm EST Session: Laboratory Processes and Automation “Clinical evaluation…

Genetic Signatures are pleased to be exhibiting at ASM Microbe 2017 in New Orleans, Louisiana, United States, 1-5 June 2017. The ASM Microbe conference showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application. You are invited to…

Genetic Signatures will be exhibiting at the 33rd ASM Clinical Virology Symposium (CVS) Savannah, Georgia, United States, 07-10 May 2017. Presented by ASM- The Clinical Virology Symposium is a 3-day event highlighting the relationship between rapid viral diagnosis, clinical course of viral infections and preventive and therapeutic modalities for viral infections being the theme of…

Genetic Signatures’ Chief Scientific Officer, Dr Doug Millar, will be presenting at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) on the 23rd April 2017 in Vienna, Austria. Dr Millar will present results on the development of a 3base™ Flavivirus and Alphavirus Detection kit. The test allows for the detection of 15…

Molecular diagnostics (MDx) company Genetic Signatures’ Chief Scientific Officer, Dr Doug Millar has been selected to present at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), to be held 22-25 April 2017 in Vienna, Austria. The presentation will highlight Genetic Signatures’ proprietary 3base™ technology and upcoming EasyScreenTM detection kits, including the EasyScreen™…